Publications

Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

Download PDF
Resource: Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

.

Related Articles

Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa

Link
Proteobacteria impair anti-tumor immunity in the omentum by consuming arginine

Link